Please assess the completion status of the following clinical trial:

Trial Title: Gastrectomy, Eating Behaviour and GLP-1

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* • At least 3 months post completion of treatment for gastric cancer, or prophylactic gastrectomy~  * Aged at least 18 years~ * Able to tolerate an oral glucose tolerance test~ * Able to understand and retain all information regarding the study and give informed consent.~ * Willing to receive an infusion of human albumin solution~Exclusion Criteria:~* • Have a diagnosis of diabetes~  * Have a history of untreated anaemia in the last 3 months~ * Be aged under 18 years~ * Have active gastric cancer~ * Be pregnant or attempting to conceive

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Infusion of 1% human albumin in normal saline.
- Exendin (Type: EXPERIMENTAL): Infusion of Exendin 9-39 in 1% human albumin in normal saline

Based on this trial design, predict the completion outcome and termination type (if applicable).